ArticleBiologics : targets & therapy2007

Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance.

Giovanni Martinelli et al.PubMed ↗Full text ↗

No numbers read from the abstract.